Bessemer Group Inc. Sells 3,536,542 Shares of Corteva, Inc. $CTVA

Bessemer Group Inc. lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 97.7% in the third quarter, HoldingsChannel.com reports. The firm owned 81,773 shares of the company’s stock after selling 3,536,542 shares during the period. Bessemer Group Inc.’s holdings in Corteva were worth $5,530,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Gladwyn Financial Advisors Inc. acquired a new position in Corteva during the 2nd quarter valued at about $25,000. Activest Wealth Management lifted its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. True Wealth Design LLC boosted its position in shares of Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares during the last quarter. Total Investment Management Inc. bought a new stake in Corteva during the second quarter worth $27,000. Finally, Curat Global LLC raised its position in Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after buying an additional 179 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

Corteva Trading Up 0.2%

Shares of CTVA stock opened at $72.63 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a market cap of $49.08 billion, a P/E ratio of 45.97, a PEG ratio of 1.84 and a beta of 0.75. The company has a 50 day moving average of $68.82 and a 200-day moving average of $68.39. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $77.41.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the company earned $0.32 earnings per share. Corteva’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CTVA. Wells Fargo & Company upped their target price on shares of Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday. Oppenheimer set a $86.00 price objective on shares of Corteva in a research report on Thursday. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday. Finally, Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $82.37.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.